{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:16:01Z","timestamp":1791285361419,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/mnm.0b013e328333d303","type":"journal-article","created":{"date-parts":[[2010,1,30]],"date-time":"2010-01-30T02:27:16Z","timestamp":1264818436000},"page":"201-205","source":"Crossref","is-referenced-by-count":44,"title":["Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?"],"prefix":"10.1097","volume":"31","author":[{"given":"Carsten","family":"Kobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Eschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Rahlff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Sudbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Dietlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Schicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210212","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2265.2007.02841.x","article-title":"Radioiodine treatment for benign thyroid diseases","volume":"66","author":"Weetman","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R2-4-20210212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1995.tb02039.x","article-title":"Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile?","volume":"43","author":"Jarlov","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R4-4-20210212","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1160\/nukmed-0283","article-title":"Procedure guideline for radioiodine test (version 3)","volume":"46","author":"Dietlein","year":"2007","journal-title":"Nuklearmedizin"},{"key":"R5-4-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.2002-020805","article-title":"A randomized comparison of radioiodine doses in Graves' hyperthyroidism","volume":"88","author":"Leslie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-4-20210212","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0038-1629650","article-title":"The value of the radioiodine uptake test for the calculation of therapeutic doses for benign thyroid disorders","volume":"32","author":"N\u00fcchel","year":"1993","journal-title":"Nuklearmedizin"},{"key":"R7-4-20210212","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jama.1973.03230090011002","article-title":"Low remission after therapy for Graves disease","volume":"226","author":"Wartofsky","year":"1973","journal-title":"JAMA"},{"key":"R8-4-20210212","first-page":"449","article-title":"New normal ranges for the radioiodine uptake study","volume":"11","author":"Bernhard","year":"1970","journal-title":"J Nucl Med"},{"key":"R9-4-20210212","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MNM.0b013e32832b5ccc","article-title":"Radioiodine therapy for thyroid volume reduction of large goitres","volume":"30","author":"Bachmann","year":"2009","journal-title":"Nucl Med Commun"},{"key":"R10-4-20210212","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1055\/s-2008-1070506","article-title":"Volumetric analysis of thyroid lobes by real-time ultrasound","volume":"106","author":"Brunn","year":"1981","journal-title":"Dtsch Med Wschr"},{"key":"R11-4-20210212","article-title":"MIRD Pamphlet No. 11: S absorbed dose per unit cumulated activity for selected radionuclides and organs (PART2)","author":"Snyder","year":"1975"},{"key":"R12-4-20210212","first-page":"1073","article-title":"High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease","volume":"87","author":"Alexander","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-4-20210212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/eje.0.1410117","article-title":"Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and other possible factors affecting outcome","volume":"141","author":"Catargi","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"R14-4-20210212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2265.2008.03291.x","article-title":"Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidsim","volume":"70","author":"Boelaert","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R15-4-20210212","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice. Graves' disease","volume":"358","author":"Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-4-20210212","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/rpd\/nch013","article-title":"Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism","volume":"108","author":"J\u00f6nsson","year":"2004","journal-title":"Radiat Prot Dosimetry"},{"key":"R17-4-20210212","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3413\/nukmed-0087","article-title":"Graves' disease and radioiodine therapy: is success of ablation dependent on the achieved dose above 200\u2009Gy?","volume":"47","author":"Kobe","year":"2008","journal-title":"Nuklearmedizin"},{"key":"R18-4-20210212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2001-11015","article-title":"Thyroid volumes and urinary iodine in German school children","volume":"109","author":"Rendl","year":"2001","journal-title":"Exp Clin Endocrinol Diab"},{"key":"R19-4-20210212","first-page":"1632","article-title":"Optimized dose planning of radioiodine therapy of benign thyroidal diseases","volume":"34","author":"Bockisch","year":"1993","journal-title":"J Nucl Med"},{"key":"R20-4-20210212","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00259-007-0419-0","article-title":"Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?","volume":"34","author":"Sisson","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0b013e328333d303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:55Z","timestamp":1786040335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-201003000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328333d303","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}